HGC Urges UK to Review Biomarker Patent Policies | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The UK needs to start developing a plan to review its policies and practices regarding DNA and biomarker patents and how these programs are monitored and managed, according to a new report issued by the Human Genetics Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.